Sanara MedTech
SMTI
58 hedge funds and large institutions have $36.1M invested in Sanara MedTech in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
15% more capital invested
Capital invested by funds: $31.4M → $36.1M (+$4.68M)
12% more funds holding
Funds holding: 52 → 58 (+6)
0.33% more ownership
Funds ownership: 12.45% → 12.78% (+0.33%)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Squarepoint
New York
|
+$734K |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$626K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$577K |
| 4 |
Goldman Sachs
New York
|
+$290K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$250K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$263K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$257K |
| 3 |
BlackRock
New York
|
-$248K |
| 4 |
Millennium Management
New York
|
-$235K |
| 5 |
HF
HRT Financial
New York
|
-$228K |
SMTI Hedge Fund Activity: Q3 2025 in Review
58 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2025, worth a combined $36.1M — up 15% from $31.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new SMTI positions and 7 closed out — a net gain of 6 holders — while 13 added to existing stakes and 21 trimmed.
The largest buyer was Squarepoint, adding an estimated $734K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $263K sold.
- 58 institutional investors held Sanara MedTech (SMTI) as of Q3 2025, up from 52 in Q2 2025.
- Funds reported $36.1M of Sanara MedTech stock for Q3 2025, up 15% quarter-over-quarter.
- 13 funds opened new Sanara MedTech positions in Q3 2025 and 7 closed out, a net change of +6 holders.
- The largest Sanara MedTech buyer in Q3 2025 was Squarepoint, an estimated $734K added.
- The largest Sanara MedTech seller in Q3 2025 was Susquehanna International Group, an estimated $263K sold.
Based on aggregated 13F filings for Q3 2025.